Evidence map›Paper›PMID 28421452›Full record

ArticleMycopathologia2017

Susceptibility of Candida albicans from Cystic Fibrosis Patients.

Raquel Sabino, Elisabete Carolino, Richard B Moss, Niaz Banaei, Cristina Verissimo, David A Stevens

Abstract read
PubMed Publisher
In one paragraph

Article in Mycopathologia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Raquel SabinoInfectious Diseases Department, National Institute of Health Dr. Ricardo Jorge, URSZ, Lisbon, Portugal. raquel.sabino@insa.min-saude.pt.ORCID http://orcid.org/0000-0001-6585-7775
Elisabete CarolinoScientific Area of Mathematics, Lisbon School of Health Technology, Polytechnic Institute of Lisbon, Lisbon, Portugal.
Richard B MossDivision of Pulmonology, Department of Pediatrics, Stanford School of Medicine, Stanford University, Stanford, CA, 94305, USA.
Niaz BanaeiDepartment of Pathology, Stanford School of Medicine, Stanford University, Stanford, CA, 94305, USA.
Cristina VerissimoInfectious Diseases Department, National Institute of Health Dr. Ricardo Jorge, URSZ, Lisbon, Portugal.
David A StevensDivision of Infectious Disease and Geographic Medicine, Department of Medicine, Stanford School of Medicine, Stanford University, Stanford, CA, 94305, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Candida albicans is a common microbe, colonizer and potential pathogen found in respiratory cultures of cystic fibrosis (CF) patients. Because of possible development of resistance in patient isolates resulting from residence in the abnormal milieu of CF patient airways, or from exposure to antifungals, and considering the possibility of patient-to-patient spread of microbes and reports of elevated resistance to other fungal pathogens, it was important to assay the susceptibility of isolates of Candida and compare that profile to isolates from the community. In our center, and unlike another fungal pathogen, no increase in resistance of Candida isolates of the CF cohort was found.

Indexed as

Drug Resistance, FungalAntifungal AgentsCandida albicansCandidiasisCarrier StateChildCross-Sectional StudiesCystic FibrosisHumansMicrobial Sensitivity TestsAntifungal AgentsCandidaCystic fibrosisDrug susceptibilityFluconazoleFungal pathogens

Identifiers

PMID28421452

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.